CoChat

Chemotherapy-induced complement signaling modulates immunosuppression and metastatic relapse in breast cancer

Open access
Monteran, Lea, Ershaid, Nour, Doron, Hila, Zait, Yael, Scharff, Ye’ela, Ben-Yosef, Shahar, Avivi, Camila, Barshack, Iris, Sonnenblick, Amir, Erez, Neta · 2022 · Nature Communications
Cited by 144

The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.

Abstract

Mortality from breast cancer is almost exclusively a result of tumor metastasis and resistance to therapy and therefore understanding the underlying mechanisms is an urgent challenge. Chemotherapy, routinely used to treat breast cancer, induces extensive tissue damage, eliciting an inflammatory response that may hinder efficacy and promote metastatic relapse. Here we show that systemic treatment with doxorubicin, but not cisplatin, following resection of a triple-negative breast tumor induces the expression of complement factors in lung fibroblasts and modulates an immunosuppressive metastatic niche that supports lung metastasis. Complement signaling derived from cancer-associated fibroblasts (CAFs) mediates the recruitment of myeloid-derived suppressor cells (MDSCs) to the metastatic niche, thus promoting T cell dysfunction. Pharmacological targeting of complement signaling in combination with chemotherapy alleviates immune dysregulation and attenuates lung metastasis. Our findings suggest that combining cytotoxic treatment with blockade of complement signaling in triple-negative breast cancer patients may attenuate the adverse effects of chemotherapy, thus offering a promising approach for clinical use.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-022-33598-x

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 17 references

Cited by

See all 144

Metadata

Authors
Monteran, L., Ershaid, N., Doron, H., Zait, Y., Scharff, Y., Ben-Yosef, S., Avivi, C., Barshack, I., Sonnenblick, A., & Erez, N.
Venue
Nature Communications
Published
2022-10-02
Volume
13
Issue
1
Pages
5797-5797
ISSN
2041-1723 (ISSN-L)
OpenAlex
W4299286463
Cited by
144
References
17
FWCI
8.72
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Chemotherapy-induced complement signaling modulates immunosuppression and metastatic relapse in breast cancer. https://app.cochat.ai/papers/10.1038/s41467-022-33598-x
The paper
Monteran, L., Ershaid, N., Doron, H., Zait, Y., Scharff, Y., Ben-Yosef, S., Avivi, C., Barshack, I., Sonnenblick, A., & Erez, N. (2022). Chemotherapy-induced complement signaling modulates immunosuppression and metastatic relapse in breast cancer. Nature Communications. https://doi.org/10.1038/s41467-022-33598-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.